Group One Trading’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-155
Closed -$3K 8439
2022
Q2
$3K Buy
155
+37
+31% +$821 ﹤0.01% 7341
2022
Q1
$4K Hold
118
﹤0.01% 7576
2021
Q4
$5K Buy
+118
New +$7.07K ﹤0.01% 7662

Other funds holding ASLN

Group One Trading's ASLN Position: Q3 2023 in Review

Group One Trading sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2023, closing a stake of 51 shares — an estimated $1.5K sold.

Group One Trading first reported a position in ASLN in Q3 2021 and held it in 8 quarters. The position peaked at $30K in Q3 2021. 19 funds tracked by Wall St. Rank hold ASLN as of Q3 2023.

  • Group One Trading reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 51 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2023, an estimated $1.5K.
  • Group One Trading first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2021 and held it in 8 quarters.
  • Group One Trading's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $30K in Q3 2021.
  • 19 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.